Add BrightSurf on Google Email

University of Iowa Health Care


TENS improves pain and fatigue in fibromyalgia

A new study led by University of Iowa Health Care researchers found that TENS reduced movement-evoked pain and fatigue in patients with fibromyalgia, with effects lasting for at least six months. The treatment was also shown to be safe, effective, inexpensive, and readily available.

SourceUniversity of Iowa Health Care·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateMar 27, 2026

Breakthrough pediatric kidney therapy emerges from U. Iowa research

Researchers at the University of Iowa Health Care have developed a new class of medication, pegcetacoplan, which directly targets the root cause of C3 glomerulopathy, a rare and severe kidney disease. The treatment has shown significant results, with up to 67% of children achieving complete remission and stabilization of kidney function.

SourceUniversity of Iowa Health Care·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateDec 3, 2025

U Iowa study links multiple sclerosis with distinct oral microbiome

Researchers found that people with MS have a distinct oral microbiome compared to healthy individuals, characterized by a loss of beneficial bacteria and an increase in disease-causing bacteria. The study suggests that oral microbial and metabolic changes may contribute to inflammation and disease processes in MS.

SourceUniversity of Iowa Health Care·Journalnpj Biofilms and Microbiomes·TypeExperimental study·DateOct 22, 2025

High-dose IV vitamin C plus chemotherapy doubles survival in advanced pancreatic cancer

A randomized phase 2 clinical trial shows that adding high-dose, intravenous vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. Patients also experience improved quality of life with reduced side effects.

SourceUniversity of Iowa Health Care·JournalRedox Biology·TypeRandomized controlled/clinical trial·DateNov 18, 2024

Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy

Researchers developed a drinkable foam infused with carbon monoxide to enhance the effectiveness of autophagy inhibition in treating various cancers. The study showed significant reductions in tumor growth and progression in mice and human cancer cells, opening a promising new approach for therapies.

SourceUniversity of Iowa Health Care·JournalAdvanced Science·TypeExperimental study·DateJan 12, 2024

Alternative bladder cancer treatment emerges amid worldwide shortage of standard of care BCG

A new study finds that a combination of chemotherapy drugs performs better than BCG in preventing high-grade cancer recurrence in patients with non-muscle invasive bladder cancer. This alternative treatment has shown excellent safety and efficacy outcomes, providing a viable option for patients facing a shortage of standard care treatm...

SourceUniversity of Iowa Health Care·JournalJAMA Network Open·TypeData/statistical analysis·DateFeb 28, 2023

New study finds distinct brain networks associated with risk and resilience in depression

A new study has identified two distinct brain networks associated with risk and resilience in depression. The salience network is linked to increased depression symptoms, while the default mode network is linked to decreased depression symptoms. These findings may lead to new treatments for depression using neuromodulation therapies.

SourceUniversity of Iowa Health Care·JournalBrain·TypeImaging analysis·DateOct 13, 2022

Study identifies genetic risks for suicide death in individuals with bipolar disorder

A new study found that diagnosis of post-traumatic stress disorder (PTSD) or genetic predisposition to PTSD is associated with increased risk of suicide death among individuals with bipolar disorder. The research suggests that understanding the genetic contribution to PTSD can help identify different strategies for suicide prevention.

SourceUniversity of Iowa Health Care·JournalTranslational Psychiatry·DateJul 8, 2021

Iowa and Ohio team finds strategy to protect developing brain from prenatal stress in mice

A study by University of Iowa researchers found that administering a neuroprotective compound during pregnancy can prevent long-term neurodevelopmental problems associated with prenatal stress. The research showed that the compound, P7C3-A20, protected the developing brain from damage caused by chronic prenatal stress.

SourceUniversity of Iowa Health Care·JournalAntioxidants and Redox Signaling·DateJan 29, 2021

Cystic fibrosis carriers are at increased risk for cystic fibrosis-related conditions

Researchers found that people with one mutated copy of the cystic fibrosis gene, known as CF carriers, are at higher risk for various CF-related conditions, including pancreatitis and type 1 diabetes. The study's results suggest a substantial burden of illness from these conditions, impacting over 10 million Americans.

SourceUniversity of Iowa Health Care·JournalProceedings of the National Academy of Sciences·DateJan 8, 2020